They decided to test their hypothesis with a drug known as JQ1. This drug was originally developed as a cancer treatment, and ...

H, three teams of researchers have regrown bone and cartilage, even entire knees, in animal studies. Human trials are not far ...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support ...

Another – a compact former powerlifter competing for the first time – had muscles that seemed impossibly dense. Even the also-rans had distinct strengths and weaknesses. The highlight, though, was a ...

Knowing she could pass on a rare genetic condition called MEN-1 made the decision to have children feel impossibly heavy for ...

When Grace Kendall speaks these days, her Aurora Christian teammates listen. That’s because Kendall, one of just three ...

Shares slightly lower as oil resumes gains after Iran shuts Strait of Hormuz; Bendigo Bank to cut jobs; Orora downgrades earnings, pauses buyback. Follow live.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Science and technology editor Eric Smalley interviewed Jeffrey Skolnick, eminent scholar in ...

Lotus Technology Inc. American Depositary Shares (NASDAQ:LOT) Q4 2025 Earnings Call Transcript April 10, 2026 Lotus Technology Inc. American Depositary Shares beats earnings expectations. Reported EPS ...

Stem cells are the body's ultimate shape-shifters, sustaining tissues by balancing two competing demands: maintaining their ...

High Potential's Steve Howey is leaving as series regular, Season 2 finale cliffhanger leaves door open for him to return as ...